254 related articles for article (PubMed ID: 23921386)
1. ATP and AMP mutually influence their interaction with the ATP-binding cassette (ABC) adenylate kinase cystic fibrosis transmembrane conductance regulator (CFTR) at separate binding sites.
Randak CO; Dong Q; Ver Heul AR; Elcock AH; Welsh MJ
J Biol Chem; 2013 Sep; 288(38):27692-27701. PubMed ID: 23921386
[TBL] [Abstract][Full Text] [Related]
2. Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia.
Dong Q; Ernst SE; Ostedgaard LS; Shah VS; Ver Heul AR; Welsh MJ; Randak CO
J Biol Chem; 2015 May; 290(22):14140-53. PubMed ID: 25887396
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of phosphoryl group transfer indicates that the ATP-binding cassette (ABC) transporter cystic fibrosis transmembrane conductance regulator (CFTR) exhibits adenylate kinase activity.
Randak CO; Ver Heul AR; Welsh MJ
J Biol Chem; 2012 Oct; 287(43):36105-10. PubMed ID: 22948143
[TBL] [Abstract][Full Text] [Related]
4. An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR.
Randak C; Welsh MJ
Cell; 2003 Dec; 115(7):837-50. PubMed ID: 14697202
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.
Gross CH; Abdul-Manan N; Fulghum J; Lippke J; Liu X; Prabhakar P; Brennan D; Willis MS; Faerman C; Connelly P; Raybuck S; Moore J
J Biol Chem; 2006 Feb; 281(7):4058-68. PubMed ID: 16361259
[TBL] [Abstract][Full Text] [Related]
6. A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.
Dong Q; Randak CO; Welsh MJ
Biophys J; 2008 Dec; 95(11):5178-85. PubMed ID: 18805924
[TBL] [Abstract][Full Text] [Related]
7. ADP inhibits function of the ABC transporter cystic fibrosis transmembrane conductance regulator via its adenylate kinase activity.
Randak CO; Welsh MJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2216-20. PubMed ID: 15684079
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for adenylate kinase activity in ABC ATPases.
Lammens A; Hopfner KP
J Mol Biol; 2010 Aug; 401(2):265-73. PubMed ID: 20600125
[TBL] [Abstract][Full Text] [Related]
9. Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel.
Randak CO; Welsh MJ
J Bioenerg Biomembr; 2007 Dec; 39(5-6):473-9. PubMed ID: 17965924
[TBL] [Abstract][Full Text] [Related]
10. The intact CFTR protein mediates ATPase rather than adenylate kinase activity.
Ramjeesingh M; Ugwu F; Stratford FL; Huan LJ; Li C; Bear CE
Biochem J; 2008 Jun; 412(2):315-21. PubMed ID: 18241200
[TBL] [Abstract][Full Text] [Related]
11. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
[TBL] [Abstract][Full Text] [Related]
12. A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase.
Randak C; Neth P; Auerswald EA; Eckerskorn C; Assfalg-Machleidt I; Machleidt W
FEBS Lett; 1997 Jun; 410(2-3):180-6. PubMed ID: 9237625
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels.
Tsai MF; Jih KY; Shimizu H; Li M; Hwang TC
J Biol Chem; 2010 Nov; 285(48):37663-71. PubMed ID: 20861014
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator.
Travis SM; Carson MR; Ries DR; Welsh MJ
J Biol Chem; 1993 Jul; 268(21):15336-9. PubMed ID: 7687995
[TBL] [Abstract][Full Text] [Related]
15. Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.
Okeyo G; Wang W; Wei S; Kirk KL
J Biol Chem; 2013 Jun; 288(24):17122-33. PubMed ID: 23620589
[TBL] [Abstract][Full Text] [Related]
16. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.
Aleksandrov L; Aleksandrov AA; Chang XB; Riordan JR
J Biol Chem; 2002 May; 277(18):15419-25. PubMed ID: 11861646
[TBL] [Abstract][Full Text] [Related]
17. An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.
Wang W; Roessler BC; Kirk KL
J Biol Chem; 2014 Oct; 289(44):30364-30378. PubMed ID: 25190805
[TBL] [Abstract][Full Text] [Related]
18. Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.
Wei S; Roessler BC; Icyuz M; Chauvet S; Tao B; Hartman JL; Kirk KL
FASEB J; 2016 Mar; 30(3):1247-62. PubMed ID: 26606940
[TBL] [Abstract][Full Text] [Related]
19. Differences between cystic fibrosis transmembrane conductance regulator and HisP in the interaction with the adenine ring of ATP.
Berger AL; Welsh MJ
J Biol Chem; 2000 Sep; 275(38):29407-12. PubMed ID: 10893239
[TBL] [Abstract][Full Text] [Related]
20. How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
Zwick M; Esposito C; Hellstern M; Seelig A
J Biol Chem; 2016 Jul; 291(28):14483-98. PubMed ID: 27226582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
